A Real-World Data Driven Pharmacovigilance Investigation on Drug-Induced Arrhythmia Using KAERS DB, a Korean Nationwide Adverse Drug Reporting System
- PMID: 38004477
- PMCID: PMC10674837
- DOI: 10.3390/ph16111612
A Real-World Data Driven Pharmacovigilance Investigation on Drug-Induced Arrhythmia Using KAERS DB, a Korean Nationwide Adverse Drug Reporting System
Abstract
This study aims to investigate the prevalence and seriousness of drug-induced arrhythmia and to identify predictors associated with the seriousness of arrhythmia. Drug-induced arrhythmia cases reported to the Korean Adverse Event Reporting System Database (KAERS DB) from January 2012 to December 2021 were investigated. A disproportionality test was performed to detect the association of the etiologic medication classes and types, along with patient demographic information, with the seriousness of drug-induced arrhythmia. Logistic regression was performed to investigate the predictors that increase the risk of serious arrhythmia. The most common etiologic agent for drug-induced arrhythmia was sevoflurane, whereas serious arrhythmia was most prevalent with narcotics. Antibiotics (reporting odds ratio (ROR) 4.125; 95% CI 1.438-11.835), chemotherapy (ROR 6.994; 95% CI 2.239-21.542), and iodinated contrast media (ROR 8.273; 95% CI 3.062-22.352) had a strong association with the seriousness of drug-induced arrhythmia. Among numerous etiologic agents, ioversol (ROR 16.490; 95% CI 3.589-75.772) and lidocaine (ROR 12.347; 95% CI 2.996-50.884) were more likely to be reported with serious arrhythmia. Aging and comorbidity, primarily cancer, are the most contributing predictors associated with serious arrhythmia. Further studies on the clinical significance of patient-specific predictors for the increased risk of serious drug-induced arrhythmia are warranted to promote drug safety.
Keywords: KAERS DB; RWD; adverse drug events; arrhythmia; drug safety; pharmacovigilance.
Conflict of interest statement
The authors declare no conflict of interest. The funders had no role in the design of the study; in the collection, analyses, or interpretation of data; in the writing of the manuscript; or in the decision to publish the results.
Figures
Similar articles
-
A Real-World Data Derived Pharmacovigilance Assessment on Drug-Induced Nephropathy: Implication on Gaps in Patient Care.Healthcare (Basel). 2023 Dec 31;12(1):95. doi: 10.3390/healthcare12010095. Healthcare (Basel). 2023. PMID: 38201001 Free PMC article.
-
Real-World Data-Derived Pharmacovigilance on Drug-Induced Cognitive Impairment Utilizing a Nationwide Spontaneous Adverse Reporting System.Medicina (Kaunas). 2024 Jun 23;60(7):1028. doi: 10.3390/medicina60071028. Medicina (Kaunas). 2024. PMID: 39064457 Free PMC article.
-
A nationwide pharmacovigilance investigation on trends and seriousness of adverse events induced by anti-obesity medication.J Glob Health. 2023 Sep 1;13:04095. doi: 10.7189/jogh.13.04095. J Glob Health. 2023. PMID: 37651636 Free PMC article.
-
A Comprehensive 10-Year Nationwide Pharmacovigilance Surveillance on Antibacterial Agents in Korea: Data Mining for Signal Detection of Trends and Seriousness of Adverse Events.Microorganisms. 2025 Jan 10;13(1):136. doi: 10.3390/microorganisms13010136. Microorganisms. 2025. PMID: 39858904 Free PMC article.
-
Risk factors of immune checkpoint inhibitor-associated acute kidney injury: evidence from clinical studies and FDA pharmacovigilance database.BMC Nephrol. 2023 Apr 22;24(1):107. doi: 10.1186/s12882-023-03171-9. BMC Nephrol. 2023. PMID: 37087434 Free PMC article.
Cited by
-
Antipsychotics and Risks of Cardiovascular and Cerebrovascular Diseases and Mortality in Dwelling Community Older Adults.Pharmaceuticals (Basel). 2024 Jan 30;17(2):178. doi: 10.3390/ph17020178. Pharmaceuticals (Basel). 2024. PMID: 38399393 Free PMC article.
References
-
- Li H., Song X., Liang Y., Bai X., Liu-Huo W.-S., Tang C., Chen W., Zhao L. Global, regional, and national burden of disease study of atrial fibrillation/flutter, 1990–2019: Results from a global burden of disease study, 2019. BMC Public Health. 2022;22:2015. doi: 10.1186/s12889-022-14403-2. - DOI - PMC - PubMed
Grants and funding
LinkOut - more resources
Full Text Sources
Miscellaneous